These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19125988)

  • 1. Targeting triglycerides in secondary prevention: should we bother?
    Athyros VG; Kakafika AI; Wierzbicki AS; Karagiannis A; Mikhailidis DP
    Int J Clin Pract; 2009 Jan; 63(1):15-8. PubMed ID: 19125988
    [No Abstract]   [Full Text] [Related]  

  • 2. A polypill for secondary prevention: time to move from intellectual debate to action.
    Fuster V; Sanz G
    Nat Clin Pract Cardiovasc Med; 2007 Apr; 4(4):173. PubMed ID: 17380163
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatal and nonfatal cardiovascular disease and the use of therapies for secondary prevention in a rural region of India.
    Joshi R; Chow CK; Raju PK; Raju R; Reddy KS; Macmahon S; Lopez AD; Neal B
    Circulation; 2009 Apr; 119(14):1950-5. PubMed ID: 19332466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of anticholesteremic agents].
    Kimura T; Kudo H
    Naika; 1968 Mar; 21(3):535-43. PubMed ID: 5685635
    [No Abstract]   [Full Text] [Related]  

  • 5. Fantastic voyage through cardiology: from 1969 to 2008.
    Mensah GA
    J Am Coll Cardiol; 2009 Jun; 53(23):2197; author reply 2197-8. PubMed ID: 19497449
    [No Abstract]   [Full Text] [Related]  

  • 6. Rosuvastatin for cardiovascular prevention: too many uncertainties.
    Prescrire Int; 2009 Aug; 18(102):176. PubMed ID: 19746571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orphans of best prevention.
    Rubba P
    Nutr Metab Cardiovasc Dis; 2007 Sep; 17(7):483-5. PubMed ID: 17628457
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels.
    Grover SA; Kaouache M; Joseph L; Barter P; Davignon J
    Arch Intern Med; 2009 Oct; 169(19):1775-80. PubMed ID: 19858435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The heart of the matter--cats and cardiovascular health.
    Mayo Clin Health Lett; 2008 Nov; 26(11):4. PubMed ID: 19048643
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors associated with recurrent coronary events among patients with cardiovascular disease.
    McConnell KJ; Olson KL; Delate T; Merenich JA;
    Pharmacotherapy; 2009 Aug; 29(8):906-13. PubMed ID: 19637943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excerpts from the casebook of Jason Harbro, M.D., AME.
    Harbro J
    Aerosp Med; 1974 Apr; 45(4):452. PubMed ID: 4821744
    [No Abstract]   [Full Text] [Related]  

  • 12. A pilot randomized trial comparing an intensive versus a standard intervention in stable HIV-infected patients with moderate-high cardiovascular risk.
    Masiá M; Bernal E; Padilla S; García N; Escribano JC; Martínez E; Gutiérrez F
    J Antimicrob Chemother; 2009 Sep; 64(3):589-98. PubMed ID: 19625372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacologic treatment with statins].
    Sirtori CR
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):101-5. PubMed ID: 12497891
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sequelae of the JUPITER study. What is changing in primary prevention? (interview by Dr. med. Dirk Einecke)].
    Parhofer K
    MMW Fortschr Med; 2008 Dec; 150(49-50):14. PubMed ID: 19130769
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cardiovascular prevention: not necessary under the age of 40].
    Walma EP
    Ned Tijdschr Geneeskd; 2009; 153():B351. PubMed ID: 19785804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins reduce cardiovascular events in primary and secondary prevention trials without causing an increase in carcinoma.
    Aronow WS
    J Am Geriatr Soc; 2009 Oct; 57(10):1942-3; author reply 1943-4. PubMed ID: 19807799
    [No Abstract]   [Full Text] [Related]  

  • 17. The Zetia challenge: an update.
    Johns Hopkins Med Lett Health After 50; 2009 Apr; 21(2):6. PubMed ID: 19489149
    [No Abstract]   [Full Text] [Related]  

  • 18. [Secondary prevention of patients with ischaemic heart disease--the reduction of LDL cholesterol level and the regression of atherosclerosis].
    Bárczi G; Merkely B
    Lege Artis Med; 2007 Oct; 17(10):675-9. PubMed ID: 19227597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Turbid serum].
    Füessl HS
    MMW Fortschr Med; 2004 Apr; 146(14):49-50. PubMed ID: 15344762
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipid management: past, present, and future.
    Betteridge DJ
    Br J Clin Pract Suppl; 1994 Dec; (77):1-10. PubMed ID: 19489168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.